We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$49.1B
AUM Growth
+$4.31B
Cap. Flow
+$1.72B
Cap. Flow %
3.51%
Top 10 Hldgs %
14.46%
Holding
3,114
New
67
Increased
2,155
Reduced
468
Closed
57

Sector Composition

Rank Sector Weight
1 Financials 14.36%
2 Healthcare 13.62%
3 Technology 13.02%
4 Industrials 11.1%
5 Energy 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBKS
3026
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$110K ﹤0.01%
7,410
KBIO
3027
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$110K ﹤0.01%
2,925
+1,375
+89% +$62.6K
INTX
3028
DELISTED
Intersections, Inc.
INTX
$108K ﹤0.01%
12,300
ONCT
3029
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$106K ﹤0.01%
40
-12
-23% -$59.7K
FCSC
3030
DELISTED
Fibrocell Science Inc.
FCSC
$104K ﹤0.01%
1,600
APP
3031
DELISTED
AMERICAN APPAREL INC COM
APP
$104K ﹤0.01%
82,600
SAUC
3032
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
$103K ﹤0.01%
15,300
ZAZA
3033
DELISTED
ZAZA ENERGY CORP COM NEW
ZAZA
$103K ﹤0.01%
9,260
ALIM
3034
DELISTED
Alimera Sciences
ALIM
$101K ﹤0.01%
1,613
PTX
3035
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$98K ﹤0.01%
3,710
-731
-16% -$23.5K
FMD
3036
DELISTED
FIRST MARBLEHEAD CORP COM STK NEW (DE)
FMD
$98K ﹤0.01%
11,990
SWSH
3037
DELISTED
SWISHER HYGIENE INC COM STK NEW (DE)
SWSH
$98K ﹤0.01%
15,460
-6,891
-31% -$58.5K
AMRS
3038
DELISTED
Amyris Inc.
AMRS
$96K ﹤0.01%
2,767
-1,948
-41% -$79.1K
TGTX icon
3039
TG Therapeutics
TGTX
$8.19B
$94K ﹤0.01%
18,200
BIOL
3040
DELISTED
Biolase, Inc.
BIOL
$91K ﹤0.01%
4
CXPO
3041
DELISTED
Crimson Exploration Inc. New Common Stock
CXPO
$91K ﹤0.01%
29,200
NETE
3042
DELISTED
NETEGRITY INC
NETE
$84K ﹤0.01%
18,500
GNK
3043
DELISTED
GENCO SHIPPING & TRADING LTD
GNK
$82K ﹤0.01%
21,500
STRP
3044
DELISTED
Straight Path Communications Inc.
STRP
$66K ﹤0.01%
+11,750
New +$61K
GGS
3045
DELISTED
GLOBAL GEOPHYSICAL SERVICES, INC COM STK
GGS
$66K ﹤0.01%
24,300
ZLCS
3046
DELISTED
ZALICUS INC COM NEW
ZLCS
$60K ﹤0.01%
8,433
LLEN
3047
DELISTED
L & L ENERGY INC COM STK (NV)
LLEN
$59K ﹤0.01%
42,800
VATE icon
3048
INNOVATE Corp
VATE
$106M
$58K ﹤0.01%
1,670
FLNA
3049
Filana Therapeutics
FLNA
$42M
$56K ﹤0.01%
2,657
CASC
3050
DELISTED
Cascadian Therapeutics, Inc.
CASC
$53K ﹤0.01%
4,283

Similar funds

Charles Schwab's Q3 2013 Portfolio in Review

As of Q3 2013, Charles Schwab held 3,114 positions worth $49.1B, up 9.6% from $44.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $1.72B of net new capital in Q3 2013, opening 67 new positions and adding to 2,155 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $76M trimmed.

  • Charles Schwab's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.
  • Charles Schwab added most to Johnson & Johnson in Q3 2013, an estimated $125M increase.
  • Charles Schwab's biggest Q3 2013 reduction was Merck, cutting an estimated $76M.
  • Charles Schwab fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $47.2M.
  • Charles Schwab's ten largest holdings make up 14% of its $49.1B portfolio in Q3 2013.
  • Charles Schwab opened 67 new positions and closed 57 in Q3 2013.
  • Charles Schwab's portfolio value rose 9.6% quarter-over-quarter to $49.1B.

Based on Charles Schwab's 13F filing for Q3 2013, filed 14 Nov 2013.